CY1343A - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
CY1343A
CY1343A CY1343A CY134380A CY1343A CY 1343 A CY1343 A CY 1343A CY 1343 A CY1343 A CY 1343A CY 134380 A CY134380 A CY 134380A CY 1343 A CY1343 A CY 1343A
Authority
CY
Cyprus
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
CY1343A
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of CY1343A publication Critical patent/CY1343A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
CY1343A 1979-03-27 1980-03-25 Therapeutic agents CY1343A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7910558 1979-03-27

Publications (1)

Publication Number Publication Date
CY1343A true CY1343A (en) 1987-01-16

Family

ID=10504143

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1343A CY1343A (en) 1979-03-27 1980-03-25 Therapeutic agents

Country Status (10)

Country Link
JP (2) JPS55130960A (en)
BE (1) BE882443A (en)
CY (1) CY1343A (en)
ES (1) ES489929A0 (en)
GB (1) GB2047691B (en)
GE (1) GEP19970835B (en)
JO (1) JO1072B1 (en)
MX (1) MX5950A (en)
SU (1) SU1124886A3 (en)
ZA (1) ZA801575B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents
IE51542B1 (en) * 1980-09-26 1987-01-07 Boots Co Ltd Therapeutic agents
US5081121A (en) * 1988-05-24 1992-01-14 Tatsushi Osawa 4(1h)-quinolone derivatives
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA801575B (en) * 1979-03-27 1981-03-25 Boots Co Ltd Therapeutic agents

Also Published As

Publication number Publication date
ES8104232A1 (en) 1981-04-16
GB2047691B (en) 1983-07-20
JPH0114224B2 (en) 1989-03-10
ZA801575B (en) 1981-03-25
GEP19970835B (en) 1997-02-10
JPS55130960A (en) 1980-10-11
MX5950A (en) 1993-11-01
JPH0250086B2 (en) 1990-11-01
BE882443A (en) 1980-09-26
GB2047691A (en) 1980-12-03
JPS62215526A (en) 1987-09-22
ES489929A0 (en) 1981-04-16
JO1072B1 (en) 1982-07-10
SU1124886A3 (en) 1984-11-15

Similar Documents

Publication Publication Date Title
PH15198A (en) Therapeutic agents
GB2000136B (en) Therapeutic agents
GB2005248B (en) Therapeutic agents
ZA782816B (en) Therapeutic agents
ZA80298B (en) Therapeutic agents
GB2000138B (en) Therapeutic agents
ZA796708B (en) Therapeutic agents
GB2000131B (en) Therapeutic agents
EG16606A (en) Therapeutic agents
ZA792390B (en) Therapeutic agents
GB2013181B (en) Therapeutic agents
GB2004876B (en) Therapeutic agents
GB2007656B (en) Therapeutic agents
GB2019836B (en) Therapeutic agents
GB2053910B (en) Pyridylaminotriazole therapeutic agents
GB2047691B (en) Therapeutic agents
GB2000510B (en) Therapeutic agents
GB2011890B (en) Therapeutic agents
GB2010824B (en) Therapeutic agents
GB2013179B (en) Therapeutic agents
GB2011891B (en) Therapeutic agents
GB2007654B (en) Therapeutic agents
GB2008104B (en) Therapeutic agents
ZA803988B (en) Novel therapeutic combinations
GB2009156B (en) Therapeutic agents